JPM

311.34

+0.76%↑

BAC

53.59

+1.17%↑

WFC

87.18

+1.49%↑

MS

163.99

-0.67%↓

AXP

360.67

+0.56%↑

JPM

311.34

+0.76%↑

BAC

53.59

+1.17%↑

WFC

87.18

+1.49%↑

MS

163.99

-0.67%↓

AXP

360.67

+0.56%↑

JPM

311.34

+0.76%↑

BAC

53.59

+1.17%↑

WFC

87.18

+1.49%↑

MS

163.99

-0.67%↓

AXP

360.67

+0.56%↑

JPM

311.34

+0.76%↑

BAC

53.59

+1.17%↑

WFC

87.18

+1.49%↑

MS

163.99

-0.67%↓

AXP

360.67

+0.56%↑

JPM

311.34

+0.76%↑

BAC

53.59

+1.17%↑

WFC

87.18

+1.49%↑

MS

163.99

-0.67%↓

AXP

360.67

+0.56%↑

Search

CorVel Corp

Uždarymo kaina

SektoriusFinansų sektorius

73.53 0.31

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

73.53

Max

75.73

Pagrindiniai rodikliai

By Trading Economics

Pajamos

816K

27M

Pardavimai

3.2M

235M

P/E

Sektoriaus vid.

38.58

27.54

Pelno marža

11.604

Darbuotojai

5,075

EBITDA

1.9M

43M

Dividendai

By Dow Jones

Kitas uždarbis

2025-11-04

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-573M

3.9B

Ankstesnė atidarymo kaina

73.22

Ankstesnė uždarymo kaina

73.53

Naujienos nuotaikos

By Acuity

50%

50%

199 / 529 reitingas Finance

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

CorVel Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-31 17:40; UTC

Įsigijimai, susijungimai, perėmimai

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

2025-10-31 23:09; UTC

Uždarbis

Review & Preview: October Surprise -- Barrons.com

2025-10-31 22:44; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

2025-10-31 21:25; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

2025-10-31 21:20; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

2025-10-31 21:12; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

2025-10-31 21:12; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

2025-10-31 21:12; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

2025-10-31 20:51; UTC

Įsigijimai, susijungimai, perėmimai

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

2025-10-31 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-10-31 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-31 20:50; UTC

Rinkos pokalbiai
Uždarbis

Auto & Transport Roundup: Market Talk

2025-10-31 20:46; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

2025-10-31 20:22; UTC

Uždarbis

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

2025-10-31 20:02; UTC

Uždarbis

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

2025-10-31 19:55; UTC

Rinkos pokalbiai

Crude Futures Fall for Third Straight Month -- Market Talk

2025-10-31 19:54; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

2025-10-31 19:54; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

2025-10-31 19:26; UTC

Rinkos pokalbiai

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

2025-10-31 18:30; UTC

Uždarbis

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

2025-10-31 18:23; UTC

Rinkos pokalbiai

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

2025-10-31 18:09; UTC

Uždarbis

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

2025-10-31 18:08; UTC

Uždarbis

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

2025-10-31 17:36; UTC

Rinkos pokalbiai

Grain Futures Shrug Off Stronger Dollar -- Market Talk

2025-10-31 17:31; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Falls, Natural Gas Rig Count Rises -- Market Talk

2025-10-31 17:16; UTC

Įsigijimai, susijungimai, perėmimai

Orange: Acquisition Likely Completed in First Half Next Year

2025-10-31 17:15; UTC

Įsigijimai, susijungimai, perėmimai

Orange: Agreement Set to Be Signed By Year-Out

2025-10-31 17:14; UTC

Įsigijimai, susijungimai, perėmimai

Orange: Acquisition Will Strengthen Position in Spain

2025-10-31 17:13; UTC

Įsigijimai, susijungimai, perėmimai

Orange Will Be Sole Owner of Spain's MasOrange Following Acquisition of Lorca's Stake

2025-10-31 17:12; UTC

Įsigijimai, susijungimai, perėmimai

Orange Reaches Deal to Buy Lorca's 50% Stake in MasOrange for EUR4.25B

Akcijų palyginimas

Kainos pokytis

CorVel Corp Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

109.75 / 112.875Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

199 / 529 reitingas Finansų sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę CorVel Corp

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
help-icon Live chat